Diazoxide
Back to searchMolecule Structure
Scientific Name
Diazoxide
Description of the Drug
Diazoxide is a non diuretic benzothiadiazine indicated for the management of hypoglycemia in patients who produce an excess of insulin caused by a variety of conditions.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01119
http://www.drugbank.ca/drugs/DB01119
Brand Name(s)
Diazoxide, Eudemine, Eudimine, Hyperstat, Mutabase, Proglycem
Company Owner(s)
Schering Corp Sub Schering Plough Corp, Teva Branded Pharmaceutical Products R And D Inc, Abraxis Pharmaceutical Products, E5 Pharma Inc, Novitium Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Potassium channel, inwardly rectifying, subfamily J, member 11 | SINGLE PROTEIN | OPENER | CHEMBL1886 |
| Potassium channel, inwardly rectifying, subfamily J, member 8 | SINGLE PROTEIN | OPENER | CHEMBL4770 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL41254 | |
| PharmGKB | PA449285 | |
| Human Metabolome Database | HMDB0015251 | |
| DrugBank | DB01119 | |
| PubChem: Thomson Pharma | 14749339 | 16616077 |
| PubChem | 3019 | |
| Mcule | MCULE-5031397425 | |
| LINCS | LSM-3639 | |
| Nikkaji | J5.703G | |
| PDBe | 20J | |
| BindingDB | 86248 | 50237612 |
| EPA CompTox Dashboard | DTXSID7022914 | |
| DrugCentral | 854 | |
| Brenda | 209384 | 93169 |
| ChemicalBook | CB8426893 | |
| Guide to Pharmacology | 2409 | |
| rxnorm | PROGLYCEM | DIAZOXIDE |
| PubChem: Drugs of the Future | 24714736 | |
| KEGG Ligand | C06949 | |
| ChEBI | 4495 | |
| ZINC | ZINC000003872277 |
